Acrivon Therapeutics (ACRV) Stock Chart & Stock Price History $5.54 -0.31 (-5.30%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.66 +0.12 (+2.08%) As of 02/21/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Acrivon Therapeutics Stock Price Performance 5 Day Performance+2.21%1 Month Performance-1.07%3 Month Performance-15.42%6 Month Performance-36.25%Year-To-Date Performance-7.97%1 Year Performance+45.03% Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ACRV Stock Chart for Saturday, February, 22, 2025 ACRV Chart by TradingView Acrivon Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$5.85$5.54-5.30%$5.94$5.5440,699 shs$172.52 million02/20/2025$5.31$5.85+10.17%$6.08$5.3552,907 shs$182.17 million02/19/2025$5.26$5.31+0.95%$5.36$5.0023,300 shs$165.35 million02/18/2025$5.42$5.26-2.95%$5.68$5.1229,710 shs$163.78 million02/17/2025$5.42$5.42$5.73$5.3119,722 shs$168.78 million02/14/2025$5.36$5.42+1.12%$5.73$5.3119,722 shs$168.78 million02/13/2025$5.16$5.36+3.88%$5.37$5.0516,113 shs$166.91 million02/12/2025$4.91$5.16+5.09%$5.16$4.9135,103 shs$160.68 million02/11/2025$5.62$4.91-12.63%$5.49$4.6979,260 shs$152.90 million02/10/2025$6.02$5.62-6.64%$6.12$5.5826,302 shs$175.01 million Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$6.51$6.02-7.53%$6.59$6.0231,865 shs$187.46 million02/06/2025$6.97$6.51-6.60%$7.24$6.3666,689 shs$202.72 million02/05/2025$5.91$6.97+17.94%$8.00$5.83736,851 shs$217.02 million02/04/2025$5.57$5.91+6.10%$5.91$5.5623,538 shs$184.04 million02/03/2025$6.07$5.57-8.24%$6.07$5.4628,444 shs$173.45 million01/31/2025$5.79$6.07+4.84%$6.28$5.8827,720 shs$189.02 million01/30/2025$5.55$5.79+4.32%$5.89$5.4612,912 shs$180.30 million01/29/2025$5.55$5.55$5.83$5.4514,918 shs$172.83 million01/28/2025$5.56$5.55-0.18%$5.60$5.2874,945 shs$172.83 million01/27/2025$5.45$5.56+2.02%$5.76$5.4526,425 shs$173.14 million01/24/2025$5.69$5.45-4.22%$5.85$5.4415,213 shs$169.71 million01/23/2025$5.60$5.69+1.61%$5.70$5.4820,717 shs$177.19 million01/22/2025$5.65$5.60-0.88%$5.81$5.3919,618 shs$174.38 million01/21/2025$5.78$5.65-2.25%$5.88$5.6524,738 shs$175.94 million Related Companies Relay Therapeutics Stock Chart Tyra Biosciences Stock Chart AnaptysBio Stock Chart Kura Oncology Stock Chart CorMedix Stock Chart Arbutus Biopharma Stock Chart Pharming Group Stock Chart Immatics Stock Chart ORIC Pharmaceuticals Stock Chart Rapport Therapeutics Stock Chart Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRV) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
